awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35229738-44CBC726-16AE-41DB-9D0F-070658D91DB9
Q35229738-44CBC726-16AE-41DB-9D0F-070658D91DB9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35229738-44CBC726-16AE-41DB-9D0F-070658D91DB9
Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study.
P2860
Q35229738-44CBC726-16AE-41DB-9D0F-070658D91DB9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35229738-44CBC726-16AE-41DB-9D0F-070658D91DB9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
adb5ad4615659f7239d7921b16a3c0deed5542e0
P2860
Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumo